1 terminated, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Calcium EDTA: new trials by email Literature Review of Calcium EDTA trials Research Report on Calcium EDTA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) Calcium EDTA, Gd-DOTA - Renal Insufficiency, Chronic, Kidney Diseases | Phase 1 / Phase 2 | Terminated | Assistance Publique - Hôpitaux de Paris | 166 | 2014-10-01 | 2018-05-18 |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2013-02-15 |
Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Infections (1) · Intraocular Lymphoma (1) · Kidney Diseases (1) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Hairy Cell (1) · Leukemia, Large Granular Lymphocytic (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Mast-Cell (1)
Assistance Publique - Hôpitaux de Paris (1) · M.D. Anderson Cancer Center (1)
France (1)
Jorge Cortes, MD (1) · Marie Courbebaisse, Doctor (1) · Patrick Chaftari, MD (1)